NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Holdings, Inc. (NYSE: HCA) today announced that it expects its Adjusted EBITDA to exceed its previously issued guidance range of $7.25 to $7.35 billion for 2014. Adjusted EBITDA for 2014 is now estimated to be approximately $7.4 billion. The Company anticipates reporting its fourth quarter 2014 results of operations and guidance for 2015 on February 3, 2015.

Fourth quarter 2014 results will include a $68 million increase in Medicaid revenues related to the reversal of the Texas Medicaid Waiver Program adjustment to reduce revenues that was recorded in the third quarter of 2014.

Same facility admissions for the fourth quarter of 2014 are expected to reflect an increase of approximately 5.0 percent and same facility emergency room visits are expected to reflect an increase of approximately 10.5 percent from the prior year's fourth quarter.

During the fourth quarter of 2014, the Company repurchased approximately 14 million shares of its common stock, completing its previously authorized $1.0 billion share repurchase program. The Company had 420,477,900 shares outstanding as of December 31, 2014.

The Company is scheduled to present Monday, January 12, at 8:00 am (PST) at the J.P. Morgan Healthcare Conference held at the Westin St. Francis Hotel in San Francisco, CA. A link to the live audio webcast is available and copies of the related presentation materials will be available at the Investor Relations section of the Company's website, www.hcahealthcare.com.

Forward-Looking Statements